Edwards Lifesciences
EW · NYSE
$88.29+$1.07 (+1.23%)TodayMarket closed ·
Prev close $87.22
EPS: actual vs estimate
Beat the estimate in 7 of the last 8 quarters, by 4.2% on average
Next report: , after the market closes
- Quarter
- Q3 FY26
- EPS estimate
- $0.74
- Revenue estimate
- $1.68B
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | $0.7627 | $0.78 | +2.3% |
| Q1 FY26 | $0.7488 | $0.78 | +4.2% |
| Q4 FY25 | $0.6363 | $0.58 | −8.8% |
| Q3 FY25 | $0.6112 | $0.67 | +9.6% |
| Q2 FY25 | $0.6418 | $0.67 | +4.4% |
| Q1 FY25 | $0.6147 | $0.64 | +4.1% |
| Q4 FY24 | $0.5706 | $0.59 | +3.4% |
| Q3 FY24 | $0.6597 | $0.67 | +1.6% |
Earnings calls
- Deutsche Bank 2026 Healthcare Summit
- EW - Earnings call Q2 2026
- Bank of America Global Healthcare Conference 2026
- EW - Earnings call Q1 2026
- Leerink Global Healthcare Conference 2026
- Barclays 28th Annual Global Healthcare Conference
- TD Cowen 46th Annual Health Care Conference
- Citi’s 2026 Unplugged MedTech and Life Sciences Access Day
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.